Cytokinetics, Incorporated (CYTK) Revenue & EPS Growth Rates 2026

Growth Analysis - CYTK

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth376.56%

5Y CAGR9.54%

10Y CAGR11.88%

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth535.10%

5Y CAGR17.55%

10Y CAGR46.04%

Equity

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	376.6%	241.9%	-2.4%	9.5%	11.9%	26.5%	12.1%	N/A
FY 2024 Dec 31, 2024	145.3%	-55.8%	-36.0%	-7.2%	-8.9%	-9.4%	1.6%	N/A
FY 2023 Dec 31, 2023	-92.0%	-67.3%	-48.7%	-24.9%	-13.1%	-3.3%	-1.7%	N/A
FY 2022 Dec 31, 2022	34.3%	30.2%	52.1%	47.9%	28.7%	13.8%	11.2%	N/A
FY 2021 Dec 31, 2021	26.2%	61.9%	30.8%	-7.9%	33.2%	23.1%	11.2%	N/A
FY 2020 Dec 31, 2020	107.8%	33.1%	61.0%	14.3%	36.0%	13.0%	N/A	N/A
FY 2019 Dec 31, 2019	-14.7%	41.8%	-36.8%	-10.6%	-10.5%	4.7%	N/A	N/A
FY 2018 Dec 31, 2018	135.6%	-45.6%	3.2%	0.6%	9.8%	7.5%	N/A	N/A
FY 2017 Dec 31, 2017	-87.4%	-31.7%	-34.2%	12.1%	-0.2%	1.1%	N/A	N/A
FY 2016 Dec 31, 2016	271.3%	50.6%	51.4%	92.7%	42.3%	18.4%	N/A	N/A
FY 2015 Dec 31, 2015	-38.9%	-3.3%	55.9%	61.9%	12.4%	N/A	N/A	N/A
FY 2014 Dec 31, 2014	53.2%	149.2%	127.2%	-10.5%	13.3%	N/A	N/A	N/A
FY 2013 Dec 31, 2013	305.5%	176.8%	128.3%	19.8%	11.2%	N/A	N/A	N/A
FY 2012 Dec 31, 2012	89.0%	71.3%	-54.7%	-11.1%	-4.0%	N/A	N/A	N/A
FY 2011 Dec 31, 2011	55.2%	-77.9%	-31.5%	5.0%	-7.2%	N/A	N/A	N/A
FY 2010 Dec 31, 2010	-96.8%	-54.4%	-42.6%	-22.0%	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	556.5%	144.7%	196.5%	43.4%	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	-8.8%	99.3%	11.7%	3.3%	N/A	N/A	N/A	N/A
FY 2007 Dec 31, 2007	335.6%	23.6%	0.4%	3.6%	N/A	N/A	N/A	N/A
FY 2006 Dec 31, 2006	-64.9%	-51.8%	-33.4%	-18.1%	N/A	N/A	N/A	N/A
FY 2005 Dec 31, 2005	-33.7%	-8.2%	-7.9%	N/A	N/A	N/A	N/A	N/A
FY 2004 Dec 31, 2004	27.1%	8.6%	16.7%	N/A	N/A	N/A	N/A	N/A
FY 2003 Dec 31, 2003	-7.2%	11.8%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	34.6%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2001 Dec 31, 2001	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - CYTK

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth376.56%

5Y CAGR9.54%

10Y CAGR11.88%

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth535.10%

5Y CAGR17.55%

10Y CAGR46.04%

Equity

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	376.6%	241.9%	-2.4%	9.5%	11.9%	26.5%	12.1%	N/A
FY 2024 Dec 31, 2024	145.3%	-55.8%	-36.0%	-7.2%	-8.9%	-9.4%	1.6%	N/A
FY 2023 Dec 31, 2023	-92.0%	-67.3%	-48.7%	-24.9%	-13.1%	-3.3%	-1.7%	N/A
FY 2022 Dec 31, 2022	34.3%	30.2%	52.1%	47.9%	28.7%	13.8%	11.2%	N/A
FY 2021 Dec 31, 2021	26.2%	61.9%	30.8%	-7.9%	33.2%	23.1%	11.2%	N/A
FY 2020 Dec 31, 2020	107.8%	33.1%	61.0%	14.3%	36.0%	13.0%	N/A	N/A
FY 2019 Dec 31, 2019	-14.7%	41.8%	-36.8%	-10.6%	-10.5%	4.7%	N/A	N/A
FY 2018 Dec 31, 2018	135.6%	-45.6%	3.2%	0.6%	9.8%	7.5%	N/A	N/A
FY 2017 Dec 31, 2017	-87.4%	-31.7%	-34.2%	12.1%	-0.2%	1.1%	N/A	N/A
FY 2016 Dec 31, 2016	271.3%	50.6%	51.4%	92.7%	42.3%	18.4%	N/A	N/A
FY 2015 Dec 31, 2015	-38.9%	-3.3%	55.9%	61.9%	12.4%	N/A	N/A	N/A
FY 2014 Dec 31, 2014	53.2%	149.2%	127.2%	-10.5%	13.3%	N/A	N/A	N/A
FY 2013 Dec 31, 2013	305.5%	176.8%	128.3%	19.8%	11.2%	N/A	N/A	N/A
FY 2012 Dec 31, 2012	89.0%	71.3%	-54.7%	-11.1%	-4.0%	N/A	N/A	N/A
FY 2011 Dec 31, 2011	55.2%	-77.9%	-31.5%	5.0%	-7.2%	N/A	N/A	N/A
FY 2010 Dec 31, 2010	-96.8%	-54.4%	-42.6%	-22.0%	N/A	N/A	N/A	N/A
FY 2009 Dec 31, 2009	556.5%	144.7%	196.5%	43.4%	N/A	N/A	N/A	N/A
FY 2008 Dec 31, 2008	-8.8%	99.3%	11.7%	3.3%	N/A	N/A	N/A	N/A
FY 2007 Dec 31, 2007	335.6%	23.6%	0.4%	3.6%	N/A	N/A	N/A	N/A
FY 2006 Dec 31, 2006	-64.9%	-51.8%	-33.4%	-18.1%	N/A	N/A	N/A	N/A
FY 2005 Dec 31, 2005	-33.7%	-8.2%	-7.9%	N/A	N/A	N/A	N/A	N/A
FY 2004 Dec 31, 2004	27.1%	8.6%	16.7%	N/A	N/A	N/A	N/A	N/A
FY 2003 Dec 31, 2003	-7.2%	11.8%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2002 Dec 31, 2002	34.6%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2001 Dec 31, 2001	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2000 Dec 31, 2000	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - CYTK

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Cytokinetics, Incorporated

Compare with peers

Explore

Growth Analysis - CYTK

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Cytokinetics, Incorporated

Compare with peers

Explore